Pennsylvania Governor Tom Corbett was on Penn Medicine’s campus last week to sign an Executive Order establishing the Pennsylvania Alzheimer’s Disease State Planning Committee. The committee will work to create a state plan to address the growing Alzheimer’s disease crisis in Pennsylvania.
“This disease touches everyone in Pennsylvania,” said Pennsylvania Secretary of Aging Brian Duke, on hand for the event, held at Penn Medicine’s Smilow Center for Translational Research.
Secretary of Aging Brian Duke will serve as the chairperson of the committee that will examine the needs and research the trends of Pennsylvania’s Alzheimer’s population.
Penn Alzheimer’s Disease Center director John Trojanowski, MD, PhD, noted that “we hope this effort helps us get closer to a world without Alzheimer’s.”
The Perelman School of Medicine at the University of Pennsylvania’s Alzheimer’s Disease Center is one of two Pennsylvania centers funded by the National Institutes of Health for advanced research in Alzheimer’s disease. Through this funding, dramatic advances have been developed for more effective therapies in treating Alzheimer’s disease.
Representing the University of Pittsburgh Medical Center was Neil Resnick, MD, who appreciated the Governor’s and Commonwealth’s efforts to advance Alzheimer’s care, research and support. “Thank you, on behalf of every citizen, as Alzheimer’s impacts individuals, families, businesses,” he said.
More than 100 Alzheimer’s advocates, researchers and clinicians were present to witness the signing, with many from the Delaware Valley Chapter of the Alzheimer’s Association. Bob Marino, Chair, Pennsylvania Public Policy Coalition for the chapter, thanked state officials for efforts to lead and adopt Alzheimer’s legislation in Pennsylvania. He noted that the committee will provide important collaboration among all Alzheimer’s stakeholders across the state.
Currently, 1 in 12 people are affected by Alzheimer’s in Pennsylvania. Recent reports estimate that the number is expected to triple by 2050.